Cadia — Blueberry Flax Granola
by CADIAMRT 176 Panel Triggers Identified
Clinical Product Assessment
Cadia manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 11 MRT-tested substances, including multiple grains, sweeteners, and oil sources. The presence of ‘natural flavor’ introduces an additional unknown variable. Due to the high concentration of tested triggers, this product is unsuitable for the initial phases of the LEAP protocol and requires professional guidance for reintroduction in Phase 3.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 11
- Safe Ingredients: 2
- Unknown/Ambiguous: 1 (natural flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| whole rolled oats | Oat | Direct Match |
| milled cane sugar | Cane Sugar | Direct Match |
| canola oil | Canola/Rapeseed | Direct Match |
| safflower oil | Safflower | Direct Match |
| sunflower oil | Sunflower | Direct Match |
| rice flour | Rice | Direct Match |
| cornstarch | Corn | Direct Match |
| honey | Honey | Direct Match |
| freeze dried blueberries | Blueberry | Direct Match |
| barley malt syrup | Barley | Direct Match |
| barley malt syrup | Malt | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: natural flavor. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 11 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 815369012652
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Oat is independently tested on the MRT panel. Found in oatmeal, granola, and many "gluten-free" products that use oat flour. Distinct from wheat sensitivity.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Canola oil (derived from rapeseed) is an MRT-tested substance. It is one of the most common cooking oils in processed foods and restaurant cooking. Look for it in fried foods, dressings, and baked goods.
Sunflower seed and sunflower oil are MRT-tested. Sunflower lecithin is increasingly used as a soy lecithin alternative. Found in chips, cooking oils, and many "allergen-friendly" products.
Rice is often used as a "safe" base in elimination diets, but some patients do react to it. Verify with your MRT results before assuming rice is safe for your Phase 1 rotation.
Corn derivatives are among the hardest triggers to avoid. Found as corn syrup, cornstarch, modified food starch, dextrose, maltodextrin, and citric acid in thousands of processed products.
Honey is tested as a distinct substance on the MRT panel. It contains proteins that can trigger mediator release independently of its sugar content. Found in many "natural" sweetened products.
Blueberry is an MRT-tested berry found in breakfast cereals, muffins, yogurts, and juice blends. Also common in supplements and "superfood" products.
What This Means For Your Diet
With 11 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 11 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from CADIA
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners